- Home
- KNOP vs ATAI Comparison
KNOP vs ATAI Comparison
Compare KNOP & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNOP | ATAI |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United Kingdom | Netherlands |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 346.6M | 1.4B |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KNOP | ATAI |
|---|---|---|
| Price | $10.74 | $4.32 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 141.2K | ★ 3.6M |
| Earning Date | 12-04-2025 | 11-12-2025 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | ★ $352,712,000.00 | $3,018,000.00 |
| Revenue This Year | $13.56 | $943.83 |
| Revenue Next Year | $2.42 | N/A |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | 17.65 | ★ 811.78 |
| 52 Week Low | $5.28 | $1.15 |
| 52 Week High | $10.99 | $6.75 |
Technical Indicators
Market Signals| Indicator | KNOP | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 66.95 | 49.78 |
| Support Level | $10.41 | $4.25 |
| Resistance Level | $10.85 | $4.54 |
| Average True Range (ATR) | 0.22 | 0.22 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 79.57 | 71.36 |
Price Performance
Historical ComparisonAbout KNOP KNOT Offshore Partners LP
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.